Adverse Cutaneous Reactions and Drugs: A Focus on Antimicrobials

References

• World Health Organisation. International Drug monitor-ing: The role of the hospital. Geneva, Switzerland: World Health Organisation; 1966. Technical Report Series No. 425.
   Google Scholar
• Bates DB, Leape LL, Petrycki S. Incidence and pre-ventability of adverse drug events in hospitalised adults. J Gen Intern Med. 1993; 8: 289–294.
   PubMed Web of Science ®Google Scholar
• Lazarou J, Pomeranz BM, Corey PN. Incidence of ADRs in hospitalised patients. A meta-analysis of prospective studies. JAMA 1998; 279: 1200–1205.
   Google Scholar
• Spector R. The Scientific Basis of Clinical Pharmacology. Principles and Examples. Boston: Little, Brown and Co, 1986.
   Google Scholar
• Davies DM. Textbook of adverse drug reactions (2nd ed) New York: Oxford University Press, 1981.
   Google Scholar
• Dukes MNG. Meyler's Side Effects of Drugs (9th ed). Amsterdam: Excerpta Medica, 1980.
   Google Scholar
• Reynolds JEF. Martindale: The Extra Pharmacopoeia (28th ed). London: Pharmaceutical Press 1982.
   Google Scholar
• Park GD, Spector R, Headstream T et al. serious adverse reactions to sulindac. Arch Intern Med 1982; 142: 1292.
   PubMed Web of Science ®Google Scholar
• Bigby M, Jick S, Jick H et al. Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. JAMA 1986; 256 (24): 3358-3363.
   Google Scholar
• Svensson CK, Cowen EW, Gaspari AA. Cutaneous drug reactions. Pharmacol Rev 2000; 53: 357–379.
   Web of Science ®Google Scholar
• Van der Linden PD, van der Lei, Vlug AE et al. Skin reactions to antibacterial agents in general practice. J Clin Epidemiol 1998; 51 (8): 703–708.
   PubMed Web of Science ®Google Scholar
• Roujeau JC, Stern RS. Severe adverse cutaneous reac-tions to drugs. NEJM 1994; 331 (19): 1272–1285.
   PubMed Web of Science ®Google Scholar
• Bigby M. Rates of cutaneous reactions to drugs. Arch Dermatol 2001; 137: 765–770.
   PubMed Web of Science ®Google Scholar
• Stevens AM, Johnson FC. A new eruptive fever associ-ated with stomatitis and ophthalmia: report of two cases in children. Am J Dis Child 1922; 24: 526–533.
   Google Scholar
• Lyell A. Toxic epidermal necrolysis: an eruption resem-bling scalding of the skin. Br J Dermatol 1956; 68: 355–361.
   PubMed Web of Science ®Google Scholar
• Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995; 333 (24): 1600–1608.
   PubMed Web of Science ®Google Scholar
• Tennis P, Stern RS. Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study. Neurology 1997; 49: 542–546.
   PubMed Web of Science ®Google Scholar
• Von Pirquet C, Schick B. Serum sickness. Baltimore: Williams and Wilkins, 1951.
   Google Scholar
• Bielory L, Yancey KB, Young NS et al. Cutaneous manifestations of serum sickness in patients receiving antithy-mocyte globulin. J Am Acad Dermatol 1985; 13: 411–417.
   PubMed Web of Science ®Google Scholar
• Warrington RJ. Martens CJ, Rubin M et al. Immunologic studies in subjects with a serum sickness-like ill-ness after immunization with human diploid cell rabies vac-cine. J Allergy Clin Immunol 1987; 79: 605–610.
   Google Scholar
• Wintroub BU, Stern R. Cutaneous drug reactions: pathogenesis and clinical classification. J Am Acad Dermatol 1985; 13: 167–179.
   PubMed Web of Science ®Google Scholar
• Dubost JJ, Souteyrand P, Sauvezie B. Drug induced vasculitides. BailBeres Clin Rheumatol 1991; 5: 119–138.
   PubMed Web of Science ®Google Scholar
• Brasile L, Kremer JM, Clarke JL et al. Identification of an autoantibody to vascular endothelial cell specific antigens in patients with systemic vasculitis. Am J Med 1989; 87: 74–80.
   PubMed Web of Science ®Google Scholar
• Anonymous. University of Maryland Medicine: Conditions: Cutaneous drug reactions. http:www.umm.edu
   Google Scholar
• Sonntag MR, Zoppi M, Fritschy D et al. Exanthema during frequent use of antibiotics and antibacterial drugs (peni-cillin, especially aminopenicillin, cephalosporin and trimetho-prim-sulphamethoxazole ) as well as allopurinol: results of the Berne Comprehensive Hospital Drug monitoring program. Schweiz Med Wochenshr 1986; 116: 142–145.
   Google Scholar
• Oberholzer B, Hoigne R, Hartman K et al. Incidence of drug side effects by symptoms and syndromes: from the expe-riences of the Comprehensive Hospital Drug Monitoring and the Swiss Drug Side Effect Center- as an example, allergic and pseudo-allergic reactions with mild analgesics and NSAID. Ther Umsch 1993; 50: 13–19.
   Google Scholar
• Hunziker T, Kunzi UP, Braunschweig S et al. Comprehensive hospital drug monitoring (CHDM): adverse skin reactions, a 20-year survey. Allergy 1997; 52: 388–393.
   Google Scholar
• Ibia E, Schwartz R, Wiederman BL. Antibiotic rashes in children: a survey on a private practice setting. Arch Dermatology 2000; 136: 849–854.
   PubMedGoogle Scholar
• Swanbeck G, Dahlberg E. Cutaneous drug reactions: and attempt to quantitative estimation. Arch Dermatol Res 1992; 284: 215–218.
   PubMed Web of Science ®Google Scholar
• Naldi L, Conforti A, Venegoni M et al. Cutaneous reac-tions to drugs: an analysis of spontaneous reports in four Italian regions. Br J Clin Pharmacol 1999; 48: 839–846.
   Google Scholar
• Torres MJ, Mayorga C, Garcia JJ et al. New aspects in betalactam recognition. Clinical and Experimental Allergy 1998; 28 (4): 25–28.
   PubMedGoogle Scholar
• de Haan P, Bruynzeel DP, van Ketel WG. Onset of penicillin rashes: relation between type of penicillin adminis-tered and type of immune reactivity. Allergy 1986; 41: 75–78.
   PubMed Web of Science ®Google Scholar
• Blanca M, Vega JM, Garcia J et al. New aspects of allergic reactions to betalactams: crossreactions and unique specificities. Clinical and Experimental Allergy 1994; 24: 407–415.
   Google Scholar
• Landsteiner K, Jacobs J. Sensitization of animals with simple chemical compounds.II. J Exp Med 1936; 63: 625.
   Google Scholar
• Eisen HN, Orris L, Selman S. Elicitation of delayed allergic skin reactions with haptens: the dependence of eliciti-zation on hapten combination with protein. J Exp Med 1952; 95: 473–87.
   PubMed Web of Science ®Google Scholar
• Edwards RG, Dewdney JM, Dobrzanski DL. Immunogenicity and allergenicity studies on two betalactam structures, a clavam, clavulanic acid, and a carbapenem: struc-ture-activity relationships. Int Archs Allergy Appl Immun 1988; 85: 184–189.
   PubMedGoogle Scholar
• Torres MJ, Gonzalez FJ, Mayorga C et al. IgG and IgE antibodies in subjects allergic to penicillins recognize different parts of the penicillin molecule. Int Arch Allergy Immunol 1997; 113: 342–344.
   Google Scholar
• Blanca M, Vega JM, Garcia J et al. Allergy to penicillin with good tolerance to other penicillins; study of the incidence in subjects allergic to betalactams. Clincal and Experimental Allergy 1990; 20: 475–481.
   Google Scholar
• Clarke A, Shakir SAW. Antibiotic-associated rashes. A literature review. Drug Safety Research Unit, Southampton, UK. 1997.
   Google Scholar
• Arndt KA, Jick H. Rates of cutaneous reactions to drugs. A report from the Boston Collaborative Drug Surveillance Program. JAMA 1976; 235 (9): 918–923.
   Google Scholar
• Prospective study of ampicillin rash. Report of a collab-orative study group. Br Med J 1973; 1: 7–9.
   Google Scholar
• Jick SS, Jick H, Dean AD. A follow-up safety study of ciprofloxacin users. Pharmacotherapy 1993; 13: 461–464.
   PubMed Web of Science ®Google Scholar
• Kubota K, Kubota N, Pearce GL et al. Signalling drug-induced rash with 36 drugs recently marketed in the United Kingdom and studied by Prescription Event Monitoring. Int J Clin Pharmacol Ther 1995; 33: 219–225.
   PubMed Web of Science ®Google Scholar
• Burge SM, Dawber RPR. Stevens-Johnson syndrome and toxic epidermal necrolysis in a patient with systemic lupus erythematosus. J Am Acad Dermatol 1985; 13: 665–666.
   PubMed Web of Science ®Google Scholar
• Roujeau JC, Huynh TN, Bracq C et al. Genetic suscep-tibility to toxic epidermal necrolysis. Arch Dermatol 1987; 123: 1171–1173.
   PubMed Web of Science ®Google Scholar
• Saiag P, Caumes E, Chosidow O et al. Drug induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus. J Am Acad Dermatol 1992; 26: 567–574.
   Google Scholar
• Rzany B, Mockenhaupt M, Stocker U et al. Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with the immune deficiency syndrome in Germany. Arch Dermatol 1993; 129: 1059–1059.
   Google Scholar
• Shapiro S, Siskind V, Slone D et al. Drug rash with ampicillin and other penicillins. Lancet 1969; 2 (628): 969–972.
   Google Scholar
• Ives TJ, Bentz EJ, Gwyther RE. Dermatologic adverse drug reactions in a family medicine setting. Arch Fam Med 1992; 1 (2) : 241–245.
   PubMedGoogle Scholar
• Anonymous. Excess of ampicillin rashes associated with allopurinol or hyperuriemia. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. N Engl J Med 1972; 286 (10): 505-507.
   Google Scholar
• Jick H, Porter JB. Potentiation of ampicillin skin reac-tions by allopurinol or hyperuricemia. J Clin Pharmacol 1981; 21 (10): 456–458.
   PubMed Web of Science ®Google Scholar
• Tillotson GS, Ball P. Fluoroquinolone safety profiles - A review. Today's Therapeutic Trends 2004; 22: 419–435.
   Google Scholar
• Lipsky BA, Baker CA. Fluoroquinolone toxicity profiles: A review focusing on newer agents. Clin Infect Dis 1999; 28: 352–364.
   PubMed Web of Science ®Google Scholar
• Factive (Gemifloxacin) For the treatment of acute exac-erbations of chronic bronchitis and community-acquired pneu-monia. Briefing document NDA#21-158 January 28, 2003. LG Life Sciences Ltd/PAREXEL/Genesoft Pharmaceuticals
   Google Scholar
• Factive prescribing information (gemifloxacin mesylate tablets) Oscient Pharmaceuticals, Waltham, MA, USA, June 2004.
   Google Scholar
• http://investors.oscient.com/phoenix.zhtml?c=97238&p=irol-newsArticle&ID=686906&highlight.
   Google Scholar